These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25437445)

  • 1. Generation of recombination activating gene-1-deficient neonatal piglets: a model of T and B cell deficient severe combined immune deficiency.
    Ito T; Sendai Y; Yamazaki S; Seki-Soma M; Hirose K; Watanabe M; Fukawa K; Nakauchi H
    PLoS One; 2014; 9(12):e113833. PubMed ID: 25437445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.
    Noordzij JG; de Bruin-Versteeg S; Verkaik NS; Vossen JM; de Groot R; Bernatowska E; Langerak AW; van Gent DC; van Dongen JJ
    Blood; 2002 Sep; 100(6):2145-52. PubMed ID: 12200379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More than just SCID--the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2.
    Niehues T; Perez-Becker R; Schuetz C
    Clin Immunol; 2010 May; 135(2):183-92. PubMed ID: 20172764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombination-activating gene 1 (Rag1)-deficient mice with severe combined immunodeficiency treated with lentiviral gene therapy demonstrate autoimmune Omenn-like syndrome.
    van Til NP; Sarwari R; Visser TP; Hauer J; Lagresle-Peyrou C; van der Velden G; Malshetty V; Cortes P; Jollet A; Danos O; Cassani B; Zhang F; Thrasher AJ; Fontana E; Poliani PL; Cavazzana M; Verstegen MM; Villa A; Wagemaker G
    J Allergy Clin Immunol; 2014 Apr; 133(4):1116-23. PubMed ID: 24332219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes.
    IJspeert H; Driessen GJ; Moorhouse MJ; Hartwig NG; Wolska-Kusnierz B; Kalwak K; Pituch-Noworolska A; Kondratenko I; van Montfrans JM; Mejstrikova E; Lankester AC; Langerak AW; van Gent DC; Stubbs AP; van Dongen JJ; van der Burg M
    J Allergy Clin Immunol; 2014 Apr; 133(4):1124-33. PubMed ID: 24418478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic Infant With Atypical SCID and Novel Hypomorphic
    Chitty-Lopez M; Westermann-Clark E; Dawson I; Ujhazi B; Csomos K; Dobbs K; Le K; Yamazaki Y; Sadighi Akha AA; Chellapandian D; Oshrine B; Notarangelo LD; Sunkersett G; Leiding JW; Walter JE
    Front Immunol; 2020; 11():1954. PubMed ID: 33117328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAG1/2 knockout pigs with severe combined immunodeficiency.
    Huang J; Guo X; Fan N; Song J; Zhao B; Ouyang Z; Liu Z; Zhao Y; Yan Q; Yi X; Schambach A; Frampton J; Esteban MA; Yang D; Yang H; Lai L
    J Immunol; 2014 Aug; 193(3):1496-503. PubMed ID: 24973446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A variant of SCID with specific immune responses and predominance of gamma delta T cells.
    Ehl S; Schwarz K; Enders A; Duffner U; Pannicke U; Kühr J; Mascart F; Schmitt-Graeff A; Niemeyer C; Fisch P
    J Clin Invest; 2005 Nov; 115(11):3140-8. PubMed ID: 16211094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of a T-B- SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection.
    Dalal I; Tabori U; Bielorai B; Golan H; Rosenthal E; Amariglio N; Rechavi G; Toren A
    Clin Immunol; 2005 Apr; 115(1):70-3. PubMed ID: 15870023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer.
    Shen Y; Xu K; Yuan Z; Guo J; Zhao H; Zhang X; Zhao L; Qing Y; Li H; Pan W; Jia B; Zhao HY; Wei HJ
    J Transl Med; 2017 Nov; 15(1):224. PubMed ID: 29100547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GvHD-associated cytokine polymorphisms do not associate with Omenn syndrome rather than T-B- SCID in patients with defects in RAG genes.
    Haq IJ; Steinberg LJ; Hoenig M; van der Burg M; Villa A; Cant AJ; Middleton PG; Gennery AR
    Clin Immunol; 2007 Aug; 124(2):165-9. PubMed ID: 17572155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A newly found homozygous mutation in recombination activating gene 1 in a patient with leaky severe combined immunodeficiency disorder.
    Salari F; Zaremehrjardi F; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Seif F; Movahedi M; Nabavi M
    Mol Biol Rep; 2019 Dec; 46(6):6571-6575. PubMed ID: 31520268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biallelic modification of IL2RG leads to severe combined immunodeficiency in pigs.
    Kang JT; Cho B; Ryu J; Ray C; Lee EJ; Yun YJ; Ahn S; Lee J; Ji DY; Jue N; Clark-Deener S; Lee K; Park KW
    Reprod Biol Endocrinol; 2016 Nov; 14(1):74. PubMed ID: 27809915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human RAG mutations: biochemistry and clinical implications.
    Notarangelo LD; Kim MS; Walter JE; Lee YN
    Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rag-1 mutations associated with B-cell-negative scid dissociate the nicking and transesterification steps of V(D)J recombination.
    Li W; Chang FC; Desiderio S
    Mol Cell Biol; 2001 Jun; 21(12):3935-46. PubMed ID: 11359901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of antibody- and B cell-deficient pigs by targeted disruption of the J-region gene segment of the heavy chain locus.
    Mendicino M; Ramsoondar J; Phelps C; Vaught T; Ball S; LeRoith T; Monahan J; Chen S; Dandro A; Boone J; Jobst P; Vance A; Wertz N; Bergman Z; Sun XZ; Polejaeva I; Butler J; Dai Y; Ayares D; Wells K
    Transgenic Res; 2011 Jun; 20(3):625-41. PubMed ID: 20872248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
    Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
    Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of RAG2 knockout pigs as animal model for severe combined immunodeficiency.
    Suzuki S; Iwamoto M; Hashimoto M; Suzuki M; Nakai M; Fuchimoto D; Sembon S; Eguchi-Ogawa T; Uenishi H; Onishi A
    Vet Immunol Immunopathol; 2016 Oct; 178():37-49. PubMed ID: 27496741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of B cell-deficient pigs by highly efficient CRISPR/Cas9-mediated gene targeting.
    Chen F; Wang Y; Yuan Y; Zhang W; Ren Z; Jin Y; Liu X; Xiong Q; Chen Q; Zhang M; Li X; Zhao L; Li Z; Wu Z; Zhang Y; Hu F; Huang J; Li R; Dai Y
    J Genet Genomics; 2015 Aug; 42(8):437-44. PubMed ID: 26336800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.
    Lev A; Simon AJ; Bareket M; Bielorai B; Hutt D; Amariglio N; Rechavi G; Somech R
    PLoS One; 2012; 7(1):e30494. PubMed ID: 22295088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.